Group Leader - Senior Director, Quantitative Pharmacology and Pharmacometrics – Oncology

Role: Senior Director, Group Leader in Quantitative Pharmacology and Pharmacometrics – Oncology, providing strategic and scientific leadership across oncology programs from post-preclinical candidate selection through registration. Responsibilities include developing and implementing integrated model-informed drug development (MIDD) strategies (PK/PD modeling, biomarker-driven dose selection, QSP, AI/ML), guiding decision-making on dose, trial design, and regulatory submissions, and overseeing a team of QP2 scientists. The role requires collaborative engagement with Clinical Development, Translational Medicine, Biostatistics, and Regulatory teams to integrate quantitative insights into development strategies. Qualifications: Ph.D. in pharmacokinetics, pharmacometrics, biomedical engineering, or related field with ≥10 years (Ph.D.) or ≥15 years (Master’s/PharmD) of pharmaceutical industry experience, including oncology expertise and regulatory interaction experience (NDA/MAA). Skills: leadership of interdisciplinary teams, advanced quantitative modeling, regulatory strategy development, and communication skills. High-Value: Oncology (small molecules, biologics, ADCs, TCEs), drug development stages from post-preclinical to registration, model-informed decision-making, and regulatory interactions. Work Setup: hybrid remote; location specifics not detailed.